EPS HEALTH TECH announced its annual performance, with a profit attributable to shareholders of HKD 38.585 million, turning a profit compared to the same period last year
EPS HEALTH TECH announced its annual results for the year ended March 31, 2025, with revenue of approximately HKD 544.5 million, a year-on-year decrease of 15.53%. The profit attributable to the company's owners was HKD 38.585 million, turning a profit compared to a loss in the previous year, with earnings per share of HKD 0.0741. The turnaround to profitability was mainly due to an increase in other income of approximately HKD 43.2 million, as well as a reduction in administrative expenses of HKD 14.4 million due to delays in the development progress of internal R&D projects
According to the Zhitong Finance APP, EPS HEALTH TECH (03860) announced its annual performance for the year ending March 31, 2025, with revenue of approximately HKD 544.5 million, a year-on-year decrease of 15.53%; the profit attributable to the company's owners was HKD 38.585 million, turning from a loss to a profit; earnings per share were HKD 0.0741.
The announcement stated that the turnaround to profit was mainly due to an increase in other income of approximately HKD 43.2 million, including income from the sale of the Japanese IRO business and internal R&D business; and a reduction in administrative expenses of HKD 14.4 million due to delays in the development progress of the internal R&D business
